The Stem Cell Institute

Casa
Panama
Panama City
The Stem Cell Institute

The Stem Cell Institute are leaders in the successful treatment of human diseases and sports injuries with proprietary Golden Cells™ adult stem cells.

Stem Cell Institute is the one of the world’s premier adult stem cell therapy and research centers. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells and allogeneic human umbilical cord tissue-derived mesenchymal stem cells to treat: multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, autoimmune diseases, cerebral palsy and autism. To-date, we’ve treated over 10,000 patients. Two single-patient Duchenne’s muscular dystrophy clinical trials using our technology for harvesting and processing mesenchymal stem cells from human umbilical cord tissue received Investigational New Drug (IND) designations from the US FDA (IND 16026 DMD Single Patient). Since then, we have published phase I/II clinical trials in peer-reviewed scientific journals for multiple sclerosis and autism. We are completing another trial for rheumatoid arthritis and plan to publish the results in late 2020 or early 2021.

27/03/2026

For Alannah, the transition from being bedridden due to systemic lupus and rheumatoid arthritis to a non-symptomatic state for over two years has been life changing.

Now, after three treatments at the Stem Cell Institute, she’s walking again, traveling, and living without symptoms controlling her life.

Alannah’s journey highlights the potential for stem cell therapy to address the underlying systemic inflammation associated with complex autoimmune conditions.

Are you or a loved one struggling with autoimmune disease? Apply today to see if you are a candidate for stem cell therapy:

https://loom.ly/fzTrbQg

26/03/2026

Navigating the world of regenerative medicine can feel overwhelming. That’s why we created a comprehensive guide to help you better understand the science, safety, and potential of Golden Cells™.

Inside this free guide, you’ll discover:

The Science: How our proprietary Golden Cells™ are carefully selected and prepared for patient use
The Experience: What a typical treatment journey in Panama may look like
Patient Stories: Insights from individuals with Autism, MS, Arthritis, and other conditions who have shared their experiences

Making informed decisions about your health starts with access to clear, research-backed information.
🔗 Download your free guide: https://loom.ly/2_ysoKU

25/03/2026

Where do mesenchymal stem cells actually come from? 🧬

In this clip, Neil Riordan, PA, PhD, breaks down the source of the stem cells used at the Stem Cell Institute. By utilizing umbilical cord tissue—material typically discarded after birth—we can access "day zero" cells.

These cells have incredible regenerative potential and can help regulate the immune system normalize without "messing with mother nature." It’s a powerful, ethical, and effective way to support the body’s recovery.

Ready to see if you're a candidate? Apply for treatment today at:

https://loom.ly/fzTrbQg

24/03/2026

Can mesenchymal stem cells support the healing of various injuries?

If you’ve been sidelined by a persistent injury or told surgery may be your only option, you may have wondered whether regenerative medicine could offer another path forward.

Mesenchymal stem cells (MSCs) are sometimes described as “ signaling cells.” These cells have the ability to migrate toward areas of injury and release bioactive molecules that may help modulate inflammation and support the body’s natural repair processes.

Researchers are exploring the potential role of MSCs in supporting recovery from several orthopedic conditions, including:

• Tendon and ligament injuries
• Muscle and soft tissue injuries
• Degenerative joint conditions like osteoarthritis
• Shoulder injuries such as rotator cuff damage
• Chronic overuse injuries like tennis elbow and tendonitis

Don't spend another season on the sidelines. See if you are a candidate for treatment by submitting an application today:

https://loom.ly/fzTrbQg

23/03/2026

Multiple Sclerosis (MS) can feel like an uphill journey—one filled with uncertainty and daily challenges. At Stem Cell Institute, we understand how important it is for patients to explore options grounded in science and guided by experience.

Mesenchymal stem cells (MSCs) are being studied for their ability to modulate the immune response and support the body’s natural repair processes. In MS, this includes exploring how these cells may help address inflammation that affects the myelin sheath.

In our 2018 clinical trial using umbilical cord–derived MSCs, patients reported improvements in areas such as bladder and bowel function, mobility, upper extremity function, and energy levels.

While results can vary for each individual, ongoing research continues to expand our understanding of how stem cell therapy may support those living with MS.

Have questions about how stem cell therapy works? Visit our website to explore published research and learn more.

19/03/2026

Autoimmune conditions occur when the immune system mistakenly attacks the body’s own cells, tissues, or organs, leading to inflammation and damage.

In this video, Neil Riordan, PA, PHD discusses how mesenchymal stem cells derived from umbilical cord tissue are being studied for their potential role in supporting immune system balance.

Research suggests these cells may help modulate immune activity, including increasing T-regulatory cells, which play an important role in helping the immune system maintain tolerance and reduce excessive inflammation.
Traditional therapies for autoimmune conditions often rely on medications such as steroids, which can have long-term side effects. Researchers are continuing to explore how regenerative medicine approaches may support the body’s natural repair processes.

See if you are eligible by applying for treatment:

https://loom.ly/fzTrbQg

17/03/2026

Halime’s son, Eridon, has experienced a "tremendous increase" in his ability to communicate his needs and emotions after stem cell therapy for autism at Stem Cell Institute.

With improved eye contact, better comprehension, and a stronger bond with his brother, Eridon's world is opening up in ways that once seemed out of reach.

Could stem cell therapy be the right path for your child?
Apply today: https://loom.ly/fzTrbQg

16/03/2026

While the idea of using your own cells sounds intuitive, the regenerative potential of your stem cells is heavily influenced by your chronological age and overall health.

❌ Myth: Using your own cells (autologous) is always best.

✅ Fact: Scientific research suggests that as we age, our own stem cell population gradually declines. These older cells may show reduced ability to migrate to areas of injury and produce the anti-inflammatory signals the body relies on for repair.

The Stem Cell Institute Difference:
At Stem Cell Institute, we utilize proprietary Golden Cells™—donor-derived umbilical mesenchymal stem cells that are carefully screened for quality and biological activity. These cells are selected to give patients the best opportunity for a favorable biological response as part of our advanced adult stem cell therapy protocols.

Learn more about Golden Cells™ on our website:

https://loom.ly/n6Y3hXA

13/03/2026

After 20 years of rotator cuff pain that surgery couldn't fix, eye surgeon Ozzy sought a different path. He chose the Stem Cell Institute to avoid a lifetime of medication and finally address the source of his chronic injury.

His recovery was rapid—by day three of treatment, the pain was essentially gone. Beyond his shoulder, he experienced surprising gains in heart health and regained sensation in fingers previously injured in a saw accident.

Are you suffering from chronic pain? Submit an application and see if regenerative medicine is right for you: https://loom.ly/fzTrbQg

12/03/2026

After a 15-year professional hockey career, including 11 seasons in the NHL, the physical toll of concussions, hip issues, and multiple surgeries left Kris searching for ways to address years of wear and tear.

Today, he’s back in the gym, and keeping up with his kids without a second thought. Regenerative medicine isn't just for the pros—it's for anyone ready to reclaim their quality of life.

See if you qualify for treatment: https://loom.ly/fzTrbQg

11/03/2026

Dr. Neil Riordan explains how his team isolated our most potent stem cells: Golden Cells™.

Through a rigorous retrospective analysis of our most successful cases, we isolated six specific cell lines of human umbilical cord tissue-derived mesenchymal stem cells (hUCT-MSCs) responsible for "miracle" recoveries. These are Golden Cells™—screened for optimal healing and regeneration and are the foundation of our treatments, providing patients with the best opportunities for optimal outcomes.

Are you a candidate for Golden Cells™ treatment? We specialize in treating conditions like Autism, Multiple Sclerosis, Heart Failure, and Osteoarthritis. Take the first step toward your recovery today - https://loom.ly/fzTrbQg

Dirección

BICSA Financial Center 63rd Fl
Panama City

Página web

https://www.cellmedicine.com/stem-cell-institute-panama-contact-us/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando The Stem Cell Institute publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto El Consultorio

Enviar un mensaje a The Stem Cell Institute:

Atajos

¿Quieres que tu consultorio sea el Clínica mas cotizado en Panama City?

Categoría

Laboratorio médico

Our Story

Two single-patient Duchenne’s muscular dystrophy clinical trials using our technology for harvesting and processing mesenchymal stem cells from human umbilical cord tissue received Investigational New Drug (IND) designations from the US FDA (IND 16026 DMD Single Patient).

Since then, we have published phase I/II clinical trials in peer-reviewed scientific journals for multiple sclerosis and autism. We are completing another trial for rheumatoid arthritis and plan to publish the results in late 2020 or early 2021.